David A. Melnick - Chief Medical Officer at Spero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Medical Officer
Stock Symbol
SPRO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David A. Melnick since 9/11/2023

Holdings reported by David A. Melnick for Spero Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 62.1K $78.8K $1.27 Feb 1, 2022 Direct
Stock Option (Right to Buy) 53.2K $59.6K $1.12 Feb 1, 2022 Direct Common Stock

Transactions reported by David A. Melnick for Spero Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.